Scott Kopetz, MD

Scott Kopetz, MD, associate professor of GI Medical Oncology at MD Anderson Center, advises community oncologists on what testing should be done for patients with colorectal cancer (CRC).

Updated guidelines suggest microsatellite testing (MSI) for every patient with CRC regardless of their stage. This will help in discovering the available novel therapies for your patient, Kopetz said. Other testing for this patient population should include KRAS, NRAS, and BRAF, which is currently considered a standard in this field.

Videos

Scott Kopetz, MD, associate professor of GI Medical Oncology at MD Anderson Center, advises community oncologists on what testing should be done for patients with colorectal cancer.

Scott Kopetz, MD | Authors

Articles

Expert Highlights Testing Standards in Patients With Colorectal Cancer